This company has been acquired
Xybion Digital Inkomsten in het verleden
Verleden criteriumcontroles 1/6
Xybion Digital's earnings have been declining at an average annual rate of -36.9%, while the Healthcare Services industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 4.6% per year. Xybion Digital's return on equity is 10.9%, and it has net margins of 5.5%.
Belangrijke informatie
-36.9%
Groei van de winst
-20.9%
Groei van de winst per aandeel
| Healthcare Services Groei van de industrie | -3.9% |
| Inkomstengroei | 4.6% |
| Rendement op eigen vermogen | 10.9% |
| Nettomarge | 5.5% |
| Laatste winstupdate | 31 Dec 2023 |
Recente prestatie-updates uit het verleden
Recent updates
Xybion Digital Inc.'s (CVE:XYBN) Share Price Boosted 80% But Its Business Prospects Need A Lift Too
May 21
Xybion Digital (CVE:XYBN) Has A Pretty Healthy Balance Sheet
Feb 24Shareholders Will Be Pleased With The Quality of Xybion Digital's (CVE:XYBN) Earnings
Nov 28Companies Like Xybion Digital (CVE:XYBN) Can Afford To Invest In Growth
Nov 03Will Xybion Digital (CVE:XYBN) Spend Its Cash Wisely?
Jul 21We're Interested To See How Xybion Digital (CVE:XYBN) Uses Its Cash Hoard To Grow
Feb 11Calculating The Intrinsic Value Of Xybion Digital Inc. (CVE:XYBN)
May 02We're Hopeful That Xybion Digital (CVE:XYBN) Will Use Its Cash Wisely
Feb 23Opbrengsten en kosten
Hoe Xybion Digital geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Dec 23 | 17 | 1 | 8 | 1 |
| 30 Sep 23 | 17 | 1 | 8 | 1 |
| 30 Jun 23 | 17 | 0 | 9 | 1 |
| 31 Mar 23 | 16 | -1 | 10 | 1 |
| 31 Dec 22 | 17 | -1 | 10 | 1 |
| 30 Sep 22 | 16 | -3 | 9 | 1 |
| 30 Jun 22 | 17 | -2 | 8 | 1 |
| 31 Mar 22 | 17 | -1 | 7 | 1 |
| 31 Dec 21 | 17 | 0 | 7 | 2 |
| 30 Jun 21 | 15 | 2 | 6 | 1 |
| 31 Mar 21 | 14 | 2 | 6 | 1 |
| 31 Mar 20 | 15 | 1 | 6 | 1 |
| 31 Mar 19 | 14 | 2 | 5 | 1 |
Kwaliteitswinsten: XYBN has a large one-off loss of $639.9K impacting its last 12 months of financial results to 31st December, 2023.
Groeiende winstmarge: XYBN became profitable in the past.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: XYBN's earnings have declined by 36.9% per year over the past 5 years.
Versnelling van de groei: XYBN has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Winst versus industrie: XYBN has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare Services industry (8.3%).
Rendement op eigen vermogen
Hoge ROE: XYBN's Return on Equity (10.9%) is considered low.